Back to drug

The Drug-Induced Respiratory Disease Website

Antiphospholipid- or antisynthetase Ab syndrome (APS-APLS). Including circulating lupus anticoagulant, anticardiolipin Ab and anti-beta2glycoprotein Ab. Possible complications include VTE, pulmonary thromboembolism, pulmonary hypertension, DAH and ILD

Publications

Kolarz B, Majdan M, Darmochwal-Kolarz DA, Dryglewska M

Antiphospholipid antibodies during 6-month treatment with infliximab: a preliminary report.

Medical science monitor : international medical journal of experimental and clinical research 2014 Jul 16;20;1227-31 — 2014 Jul 16 — 1227-31

Nosbaum A, Goujon C, Fleury B, Guillot I, Nicolas JF, Bérard F

Arterial thrombosis with anti-phospholipid antibodies induced by infliximab.

European journal of dermatology : EJD 2007 Nov-Dec;17;546-7 — 2007 Nov-Dec — 546-7

Eklund KK, Peltomaa R, Leirisalo-Repo M

Occurrence of pulmonary thromboembolism during infliximab therapy.

Clinical and experimental rheumatology 2003 Sep-Oct;21;679 — 2003 Sep-Oct — 679